Antibiotic-treated infections in intensive care patients in the UK

被引:8
作者
Cuthbertson, BH [1 ]
Thompson, M
Sherry, A
Wright, MM
Bellingan, GJ
机构
[1] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland
[2] St Thomas Hosp, Intens Care Unit, London, England
[3] James Paget Hosp, Intens Care Unit, Gorleston, Norfolk, England
[4] Univ Coll Hosp, Intens Care Unit, London, England
关键词
intensive care; infection; antibiotics;
D O I
10.1111/j.1365-2044.2004.03742.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The purpose of this audit was to study reasons for starting antibiotic therapy, duration of antibiotic treatment, reasons for changing antibiotics and the agreement between clinical suspicion and microbiological results in intensive care practice. We conducted a multicentre observational audit of 316 patients. Data on demographic details, site, treatment and nature of infection were collected. The median duration of antibiotic therapy was 7 days. Infections were community-acquired in 160 patients (55%). Antibiotics were started on clinical suspicion of infection in 237 patients (75%). Pulmonary infections were the most common, representing 52% of all proven infections. Gram-negative organisms were the most common cause of proven infections (n = 90 (50%)). The antibiotic spectrum was narrowed in light of microbiology results in 78 patients (43%) and changed due to antibiotic resistance in 38 patients (21%). We conclude that the mean duration of treatment contrasts with existing published guidelines, highlighting the need for further studies on duration and efficacy of treatment in intensive care.
引用
收藏
页码:885 / 890
页数:6
相关论文
共 21 条
  • [1] [Anonymous], 1989, AM REV RESPIR DIS, V139, P1058
  • [2] Indications for antibiotic use in ICU patients: a one-year prospective surveillance
    Bergmans, DCJJ
    Bonten, MJM
    Gaillard, CA
    vanTiel, FH
    vanderGeest, S
    deLeeuw, PW
    Stobberingh, EE
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (04) : 527 - 535
  • [3] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [4] Top ten list in antibiotic policy in the ICU
    Diaz, E
    Rello, J
    [J]. CHEST, 2002, 122 (02) : 712 - 714
  • [5] Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling
    George, DL
    Falk, PS
    Wunderink, RG
    Leeper, KV
    Meduri, GU
    Steere, EL
    Corbett, CE
    Mayhall, CG
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (06) : 1839 - 1847
  • [6] Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals - A challenge to hospital leadership
    Goldmann, DA
    Weinstein, RA
    Wenzel, RP
    Tablan, OC
    Duma, RJ
    Gaynes, RP
    Schlosser, J
    Martone, WJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03): : 234 - 240
  • [7] Rotation and restricted use of antibiotics in a medical intensive cave unit - Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria
    Gruson, D
    Hilbert, G
    Vargas, F
    Valentino, R
    Bebear, C
    Allery, A
    Bebear, C
    Gbikpi-Benissan, G
    Cardinaud, JP
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (03) : 837 - 843
  • [8] Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis
    Hails, J
    Kwaku, F
    Wilson, AP
    Bellingan, G
    Singer, M
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (03) : 481 - 483
  • [9] Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia - Chicago, Illinois, May 2002
    Hubmayr, R. D.
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 (11) : 1521 - 1536
  • [10] Experience with a clinical guideline for the treatment of ventilator-associated pneumonia
    Ibrahim, EH
    Ward, S
    Sherman, G
    Schaiff, R
    Fraser, VJ
    Kollef, MH
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (06) : 1109 - 1115